青少年和年轻人的艾滋病毒暴露前预防:最新情况
Caitlin Camfield1, Yolanda N Evans2, Raaka G Kumbhakar3
1Division of Adolescent Medicine, Department of Pediatrics, University of Washington & Seattle Children's Hospital.
Current opinion in pediatrics
|April 24, 2024
概括
新的艾滋病毒暴露前预防 (PrEP) 选择,如特诺福维尔阿拉芬胺-埃姆特里西塔宾和卡博特格拉维尔,对青少年有效. 解决吸收和遵守障碍对于增加年轻人PrEP使用至关重要.
科学领域:
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
- 青少年医学 青少年医学
背景情况:
- 青少年和年轻人在获得和坚持HIV暴露前预防 (PrEP) 时面临着独特的挑战.
- 了解不断发展的PrEP选择和持续存在的障碍对于在这个人口群体中有效的艾滋病毒预防策略至关重要.
研究的目的:
- 审查目前有关新可用的艾滋病毒暴露前预防 (PrEP) 药物的有效性和安全性的证据.
- 识别针对青少年和年轻成年人的PrEP护理障碍.
- 探索旨在改善PrEP吸收,坚持和保留的干预措施.
主要方法:
- 对艾滋病毒暴露前预防 (PrEP) 最近证据的系统审查.
- 对新药和现有PrEP药物的安全性和疗效数据的分析.
- 对针对年轻人使用PrEP的障碍和促进因素的研究进行审查.
主要成果:
- 新获批准的药物,包括特诺福维尔-阿拉芬胺-埃姆特里西塔宾和卡博特格拉维尔,在青少年艾滋病毒预防中耐受性良好,有效.
- 现在有各种PrEP选择,为个人提供量身定制的选择.
- 尽管有新的选择,但青少年和年轻成年人仍然存在大量的障碍,阻碍青少年和年轻成年人接受,坚持和留在护理中.
结论:
- 青少年和年轻人可以通过各种PrEP药物选择多样化和有效的艾滋病毒预防方法.
- 克服持续存在的障碍需要多方面的干预,包括基于技术的解决方案,加强提供者教育和导航支持.
- 改善获得和支持系统对于最大限度地提高PrEP在年轻人群中的影响至关重要.
相关概念视频
Retrovirus Life Cycles
45.9K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.9K
Sexually Transmitted Infections
303
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
303
Drug Administration and Therapy Phases: Overview
452
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
452
Transmission-based Precautions I: Contact, Enteric, and Droplets
3.6K
Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
3.6K
Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
Transmission-based Precautions II: Airborne and Protective Environment
1.2K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.2K


